Alaunos Therapeutics, Inc. (TCRT) Financials

$3.55

$0.35 (11.08%)
Last update: 04:00 PM EST
Day's range
$3.05
Day's range
$3.69
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200MEarning201820182019201920202020202120212022202220232023202420240%0%-200000%-200000%-400000%-400000%-600000%-600000%-800000%-800000%-1000000%-1000000%Profit Margin
Profit Margin
Revenue
Earnings

TCRT Income statement / Annual

Last year (2024), Alaunos Therapeutics, Inc.'s total revenue was $10.00 K, an increase of 100.00% from the previous year. In 2024, Alaunos Therapeutics, Inc.'s net income was -$4.68 M. See Alaunos Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $10.00 K $5.00 K $2.92 M $398.00 K $0.00 $0.00 $146.00 K $6.39 M $6.86 M $4.33 M
Cost of Revenue $0.00 $4.80 M $2.76 M $740.00 K $1.13 M $629.00 K $0.00 $0.00 $0.00 $0.00
Gross Profit $10.00 K -$4.80 M $163.00 K -$342.00 K -$1.13 M -$629.00 K $146.00 K $6.39 M $6.86 M $4.33 M
Gross Profit Ratio 1 -959.6 0.06 -0.86 0 0 1 1 1 1
Research and Development Expenses $362.00 K $16.28 M $25.02 M $49.64 M $52.70 M $38.33 M $34.13 M $45.08 M $157.79 M $106.79 M
General & Administrative Expenses $4.46 M $12.22 M $13.14 M $27.56 M $27.67 M $19.53 M $19.92 M $14.80 M $14.38 M $17.65 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.46 M $12.22 M $13.14 M $27.56 M $27.67 M $19.53 M $19.92 M $14.80 M $14.38 M $17.65 M
Other Expenses $0.00 $971.00 K $529.00 K -$1.20 M $385.00 K $813.00 K $631.00 K $465.00 K $134.00 K $12.00 K
Operating Expenses $4.82 M $29.47 M $38.16 M $77.21 M $80.36 M $57.86 M $54.05 M $59.88 M $172.17 M $124.43 M
Cost And Expenses $4.82 M $34.27 M $38.16 M $77.21 M $80.36 M $57.86 M $54.05 M $59.88 M $172.17 M $124.43 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $1.92 M $3.15 M $1.18 M $0.00 $0.00 $0.00 $830.00 K $0.00 $0.00
Depreciation & Amortization $2.00 K $2.32 M $2.76 M $2.60 M $1.13 M $629.00 K $573.00 K $369.00 K $290.00 K $357.00 K
EBITDA -$4.68 M -$30.90 M -$31.82 M -$74.97 M -$78.85 M -$117.17 M -$53.33 M -$53.12 M -$165.01 M -$119.73 M
EBITDA Ratio -467.7 -6180.8 -10.89 -188.37 0 0 -365.28 -8.31 -24.05 -27.64
Operating Income Ratio -481.2 -6853.4 -12.01 -194.85 0 0 -369.22 -8.37 -24.09 -27.72
Total Other Income/Expenses Net $133.00 K -$873.00 K -$2.63 M -$1.20 M $385.00 K -$59.94 M $789.00 K -$830.00 K $10.00 K $12.00 K
Income Before Tax -$4.68 M -$35.14 M -$37.73 M -$78.75 M -$79.98 M -$117.80 M -$53.12 M -$54.32 M -$165.30 M -$120.09 M
Income Before Tax Ratio -467.9 -7028 -12.91 -197.87 0 0 -363.82 -8.5 -24.09 -27.72
Income Tax Expense $0.00 $0.00 -$133.00 K -$1.86 M -$1.13 M $60.12 M -$947.00 K $2.13 M $114.00 K -$12.00 K
Net Income -$4.68 M -$35.14 M -$37.60 M -$76.89 M -$78.85 M -$177.92 M -$53.12 M -$54.32 M -$165.30 M -$120.09 M
Net Income Ratio -467.9 -7028 -12.87 -193.2 0 0 -363.82 -8.5 -24.09 -27.72
EPS -2.92 -21.97 -25.97 -53.8 -56.42 -158.9 -55.52 -59.5 -190.15 -143.63
EPS Diluted -2.92 -21.97 -25.97 -53.8 -56.42 -158.9 -55.44 -59.5 -190.15 -143.63
Weighted Average Shares Out $1.60 M $1.60 M $1.45 M $1.43 M $1.40 M $1.12 M $956.72 K $912.92 K $869.28 K $836.11 K
Weighted Average Shares Out Diluted $1.60 M $1.60 M $1.45 M $1.43 M $1.40 M $1.12 M $958.07 K $912.92 K $869.28 K $836.11 K
Link